ArticleAging2026
Stage-dependent transcriptomic changes in human dermal fibroblast senescence model.
Article in Aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular senescence is a fundamental biological process that underlies organismal aging and age-related diseases; however, the temporal dynamics of gene expression during senescence remain unclear. This study investigated gene expression changes across aging progression and the molecular mechanisms involved using three replicative senescence models of human dermal fibroblasts, designated as young, middle, and old. RNA sequencing transcriptome analysis with two independent analytical pipelines revealed that the transcriptome profiles of the young and middle stages were similar, whereas that of the old stage was distinct. Differential expression analysis showed significant gene expression changes between the young and middle stages, with differentially expressed genes (DEGs) increasing as senescence progressed. STRING and Gene Ontology/Kyoto Encyclopedia of Genes and Genomes enrichment analyses indicated early activation of immune-inflammatory response clusters and decreases in structural maintenance genes. Using an alternative DEG set, non-negative matrix factorization (NMF) decomposed transcriptomes into distinct metagenes, with characteristic senescence-stage behaviors. NMF independently recapitulated immune-inflammatory activation and the loss of structural maintenance functions. These findings suggest that immune-inflammatory responses are engaged from early senescence, whereas cell adhesion and maintenance pathways decline progressively. These results identify early biomarkers and therapeutic targets, providing opportunities to delay or mitigate aging-related functional decline.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.